Edwards Lifesciences (EW) FCF Margin Growth (1y) (2010 - 2026)
Edwards Lifesciences (EW) FCF Margin Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn | 194.00 |
| 2 | Stryker | 127.77 Bn | 124.29 Bn | 4.50 Bn | 66.00 |
| 3 | Medtronic | 119.02 Bn | 109.80 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 119.00 |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 1,788.00 |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | -395.00 |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | 112.00 |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn | -505.00 |
| 9 | Steris | 23.07 Bn | 22.58 Bn | 684.20 Mn | -473.00 |
| 10 | Zimmer Biomet Holdings | 19.21 Bn | 18.80 Bn | 1.54 Bn | 229.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,788.00 |
| Mar 31, 2026 | -1,716.00 |
| Dec 31, 2025 | 3,532.00 |
| Sep 30, 2025 | 1,109.00 |
| Jun 30, 2025 | -517.00 |
| Mar 31, 2025 | 2,482.00 |
| Dec 31, 2024 | -1,661.00 |
| Sep 30, 2024 | -650.00 |
| Jun 30, 2024 | 2,201.00 |
| Mar 31, 2024 | -2,962.00 |
| Dec 31, 2023 | -4,594.00 |
| Sep 30, 2023 | 969.00 |
| Jun 30, 2023 | -2,216.00 |
| Mar 31, 2023 | 423.00 |
| Dec 31, 2022 | 2,841.00 |
| Sep 30, 2022 | -1,701.00 |
| Jun 30, 2022 | -1,216.00 |
| Mar 31, 2022 | 46.00 |
| Dec 31, 2021 | -271.00 |
| Sep 30, 2021 | 2,608.00 |